Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Comprehensive Loss

v3.20.1
Consolidated Statements of Comprehensive Loss - CAD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Consolidated Statements of Comprehensive Loss      
Revenue $ 775,821 $ 777,302 $ 109,173
Cost of revenue 646,441 575,172 63,950
Gross profit 129,380 202,130 45,223
Operating expenses      
Amortization 1,066,906 278,621 124,134
General and administrative expenses 8,088,529 5,490,938 2,373,251
Research and development expenses 9,514,520 5,566,036 4,430,386
Sales and marketing expenses 1,743,855 1,386,901 631,381
Stock-based compensation expense 6,816,321 3,228,508 889,511
Share-based payment expense 213,720 1,109,531 1,085,716
Operating expenses (27,443,851) (17,060,535) (9,534,379)
Operating loss 27,314,471 16,858,405 9,489,156
Other items      
Interest income 99,477    
Accretion interest expense     69,562
Changes in fair value of warrant derivative 2,926,392 (7,707,051) 186,269
Finder's fee on convertible loan     258,542
Impairment of goodwill     1,342,794
Issue costs allocated to derivative liability   (1,493,554)  
Other income 89,448    
Foreign exchange loss (gain) (795,172) 605,096 (20,049)
Income tax recovery (104,799) (1,667)  
Loss before taxes (30,847,110) (10,039,812) (11,366,372)
Net loss (30,742,311) (10,038,145) (11,366,372)
Other comprehensive income/(loss) 66,210 (10,005)  
Comprehensive loss $ (30,676,101) $ (10,048,150) $ (11,366,372)
Loss per share - basic and fully diluted (in dollars per share) $ (0.85) $ (0.38) $ (0.52)
Weighted average number of shares outstanding - basic and fully diluted (in shares) 35,998,152 26,582,664 21,818,315